Modeling Cancer with Pluripotent Stem Cells

被引：28

作者：

Gingold, Julian ^{[1
]}

Zhou, Ruoji ^{[2
,3
]}

Lemischka, Ihor R. ^{[4
,5
,6
]}

Lee, Dung-Fang ^{[2
,3
,7
]}

机构：

[1] Cleveland Clin Fdn, Womens Hlth Inst, Cleveland, OH 44195 USA

[2] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA

[3] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA

[4] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA

[5] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA

[6] Icahn Sch Med Mt, Black Family Stem Cell Inst, New York, NY 10029 USA

[7] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell & Regenerat Med, Brown Fdn, Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA

来源：

TRENDS IN CANCER | 2016年 / 2卷 / 09期

关键词：

TARGETED GENE CORRECTION; FUNCTIONAL HUMAN LIVER; KIDNEY ORGANOIDS; HUMAN ES; DIRECTED DIFFERENTIATION; PROGENITOR CELLS; SELF-RENEWAL; IPS CELLS; GENERATION; DISEASE;

D O I：

10.1016/j.trecan.2016.07.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The elucidation of cancer pathogenesis has been hindered by limited access to patient samples, tumor heterogeneity, and the lack of reliable model organisms. Characterized by their ability to self-renew indefinitely and differentiate into all adult cell lineages of an organism, pluripotent stem cells (PSCs), including ESCs and induced pluripotent stem cells (iPSCs), provide a powerful and unlimited source to generate differentiated cells that can be used to study disease biology, facilitate drug discovery and development, and provide key insights for developing personalized therapies. This article reviews the recent developments and technologies converting PSCs into clinically relevant model systems for cancer research.

引用

页码：485 / 494

页数：10

共 50 条

[41] Primary immunodeficiency modeling with induced pluripotent stem cells
Pessach, Itai M.
Notarangelo, Luigi D.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (06) : 505 - 511
[42] Human disease modeling with induced pluripotent stem cells
Trounson, Alan
Shepard, Kelly A.
DeWitt, Natalie D.
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2012, 22 (05) : 509 - 516
[43] The Modeling of Werner Syndrome by Induced Pluripotent Stem Cells
Yozu, Gakuto
Yuasa, Shinsuke
Motoda, Chikaaki
Kusumoto, Dai
Kunitomi, Akira
Kashimura, Shin
Takei, Makoto
Shimojima, Masaya
Hayashiji, Nozomi
Seki, Tomohisa
Tohyama, Shugo
Yokote, Koutaro
Daita, Hiroyuki
Fukuda, Keiichi
CIRCULATION, 2015, 132
[44] Modeling Keratoconus Using Induced Pluripotent Stem Cells
Joseph, Roy
Srivastava, Om P.
Pfister, Roswell R.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (08) : 3685 - 3697
[45] Modeling Leukemia with Human Induced Pluripotent Stem Cells
Papapetrou, Eirini P.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2019, 9 (12):
[46] INDUCED PLURIPOTENT STEM CELLS
Zaehres, Holm
Kim, Jeong Beom
Schoeler, Hans R.
GUIDE TO TECHNIQUES IN MOUSE DEVELOPMENT, PT A: MICE, EMBRYOS, AND CELLS, 2ND EDITION, 2010, 476 : 309 - 325
[47] Endodermal stem cell populations derived from pluripotent stem cells
Cheng, Xin
Tiyaboonchai, Amita
Gadue, Paul
CURRENT OPINION IN CELL BIOLOGY, 2013, 25 (02) : 265 - 271
[48] Neural Differentiation of Human Pluripotent Stem Cells for Nontherapeutic Applications: Toxicology, Pharmacology, and In Vitro Disease Modeling
Yap, May Shin
Nathan, Kavitha R.
Yeo, Yin
Lim, Lee Wei
Poh, Chit Laa
Richards, Mark
Lim, Wei Ling
Othman, Iekhsan
Heng, Boon Chin
STEM CELLS INTERNATIONAL, 2015, 2015
[49] Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research
Chao, Hsiao-Mei
Chern, Edward
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2018, 117 (12) : 1046 - 1057
[50] Induced pluripotent stem cells: A new tool to confront the challenge of neuropsychiatric disorders
Vaccarino, Flora M.
Stevens, Hanna E.
Kocabas, Arif
Palejev, Dean
Szekely, Anna
Grigorenko, Elena L.
Weissman, Sherman
NEUROPHARMACOLOGY, 2011, 60 (7-8) : 1355 - 1363

← 1 2 3 4 5 →